Cancer researcher, city native part of ceremony dedicating monument to his work

Monday, 6 July 2015

New Castle NewsCancer researcher, city native part of ceremony dedicating monument to his workNew Castle NewsHe and his colleagues conducted the laboratory and clinical research that led to the development of Herceptin, a drug that targets a genetic alteration found in about 25 percent of breast cancer patients. Herceptin was approved by the U.S. Food & Drug ...